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Summary Male sex, high age and atrophic gastritis (AG) are risk conditions for gastric carcinoma (GCA).
We have studied the magnitude of the sex-bound risk of GCA and whether this risk is an independent risk
factor for GCA or whether it is related to the risks that are mediated by age and AG. The observed
frequencies of males and females in different age groups, and in presence or absence of AG, among 532 GCA
patients (273 cases of intestinal (IGCA) and 259 cases of diffuse (DGCA) type) were compared with the
expected frequencies which were calculated by applying the data of age-specific distributions of the sexes and
AG in the general population. A significant 1.6-fold overrepresentation of males and 0.6-fold under-
representation of females were seen in IGCA but not in DGCA. The overrepresentation of the male sex and
the underrepresentation of the female sex in IGCA were independent of age of the patient and location of the
tumour in the stomach. These phenomena were also independent of AG: the overrepresentation of males and
the underrepresentation of females were observed in IGCA patients with normal, non-atrophic mucosa as well
as in IGCA patients with AG. We conclude that the sex is an independent risk factor for IGCA, and that the
phenomena which lead to overrepresentation of males and underrepresentation of females among IGCA
patients (and among GCA patients in general) are unrelated to age, AG and location of the tumour in the
stomach.
Male sex, high age and atrophic gastritis (AG) are risk
conditions for gastric cancer (GCA). The incidence of GCA
is approximately twice as high in males as in females (Day,
1982), and the GCA incidence strongly increases with
increasing age in both sexes (Day, 1982; Sipponen et al.,
1984). Several follow-up and cross-sectional studies have
further shown that the risk of GCA is approximately 3-4
times as high in subjects with, than in those without, AG, a
risk which obviously increases with increasing grade of AG
(Siurala et al., 1966; Cheli et al., 1973; Meister et al., 1979;
Sipponen et al., 1985). Sex, age and AG may be independent
risk factors for GCA. Another possibility is that their action
is interrelated so that the overrepresentation of GCA among
males is, for example, due to age-dependent development
and progression of AG in the stomach. This alternative may
be supported by observations according to which there occur
changes in the male-to-female ratio (M/F) of GCA with age
(Griffith, 1968), and according to which a high M/F ratio
especially occurs in GCA of the intestinal type, i.e., in the
tumour type which particularly is related to AG in its
morphogenesis (Jiirvi & Lauren. 1951; Lauren, 1965;
Sipponen et al., 1983, 1984).
The objective of the present study was to evaluate the risk
of GCA separately in the male and female sexes and to
study further whether statistical interactions can be
demonstrated between the sex-related risk and the risks that
are mediated by age and AG. The analyses were made
separately for intestinal (IGCA) and diffuse (DGCA) types
of GCA and were based on comparisons of observed and
expected frequencies of males and females in a consecutive
series of 532 GCA patients.
Materials and methods
Gastric cancer (GCA) series
The series was collected from outpatient and patient
departments of Jorvi Hospital, Espoo, and Meilahti
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Hospital, Helsinki, during 1976-1986. The series consists of
532 consecutive cases of intestinal (IGCA; 273 cases) and
diffuse (DGCA; 259 cases) types of GCA diagnosed
according to the criteria of Lauren (1965). Cases with
undifferentiated GCA and cases with cancer in the cardiac
area of the stomach were excluded from the series, as were
those in which the location of the cancer in the stomach
could not be established. The series was divided into distal
(pylorus, prepylorus or antrum) and proximal (angular or
body area) tumours depending on the location of the tumour
at endoscopy and/or surgery. Distribution of IGCA and
DGCA cases according to sex, age and location are
presented in the tables. The mean ages of the patients in the
distal IGCA group were 69.9+9.2 years in males and
72.6+7.7 years in females, and in the proximal IGCA group
67.2+ 10.5 years in males and 72.1 +9.0 years in females.
Mean ages in the distal DGCAs were 60.4+13.0 years in
males and 55.6+15.6 years in females, and in the proximal
DGCAs 57.6+12.3 years in males and 58.4+12.0 years in
females.
In 237 GCA cases endoscopic and/or surgical biopsy
specimens were taken from the area (antrum or body), where
the tumour was situated (tumour-bearing mucosa/area), but
always apart from the tumour-affected area. Thus, for
example, in cases with pyloric tumours the specimens were
from the tumour-free area of the proximal antrum, and in
cases of body tumours from the body mucosa as far as
possible from the tumour site. The 237 cases were used to
evaluate the relationship between the sex- and AG-dependent
risks of GCA. The distribution of the cases with regard to
sex, type of the tumour and status of the gastric mucosa are
presented in the tables. The mean ages of males and females
in the IGCA group were 68.9+ I1.0 and 72.0+ 7.4 years and
in the DGCA group 57.1 + 12.0 and 55.6+ 13.8 years,
respectively.
The classification of the cases into non-atrophic (N-S) and
atrophic gastritis groups (Al-A3) was performed as
described earlier (see Siurala et al., 1984). Briefly:
-normal mucosa (N): no inflammation, no atrophy;
-superficial chronic gastritis (S): chronic inflammation
without loss of normal mucosal glands;
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-slight, moderate or severe atrophic gastritis (Al-A3): slight,
moderate or severe (total) loss of normal glands with a
varying degree of chronic inflammation.
The grades N and S were considered to represent 'non-
atrophic' mucosa, and the grades Al-A3 were included
under the epithet 'atrophic' mucosa/gastritis.
Calculation ofthe expected cancerfrequencies
The expected cancer frequencies were calculated on the basis
of the distribution of males and females into different age
groups in Finland in 1980, as shown in Table I.
In the analyses where the histological state of the tumour-
bearing mucosa was included, the expected frequencies of
GCA cases were calculated by applying the data of the
distribution of non-atrophic mucosa (N-S) and atrophic
gastritis (Al-A3) among males and females in a population
sample of 371 subjects considered to represent the general
population of South Finland (Ihamaki et al., 1979), i.e., the
area from which the GCA cases were collected. The age
group-specific prevalences for normal, non-atrophic mucosa
(N-S) and for atrophic gastritis (A1-A3) were estimated
from this sample. The sample is a family sample that was
originally collected to serve as a control material for families
of probands with gastric cancer (Ihamaki et al., 1979).
Gastroscopy with multiple biopsies from antrum and body
were performed in all subjects. The distribution of different
gastric diseases, symptoms and blood groups is similar in the
sample as in the general Finnish population. All subjects
were informed of all aspects of the study, and the
investigations were performed according to ethical rules of
the Meilahti Hospital, Helsinki.
Statistics
Significances in the deviations of the observed frequencies of
GCA (OBS) from the expected frequencies of GCA (EXP)
between the sexes in the particular age- and AG-categories
were calculated by chi-square (x2) analysis and likelihood
ratio G-tests (Sokal & Rohlf, 1981).
The ratio of the male O/E to female O/E was used to
estimate the risk of cancer in males (RISKM) when the risk
in females (RISKF) is 1.
Furthermore, the relative risk of cancer in atrophic
gastritis (RISKA-A3), when the risk in normal, non-atrophic
mucosa (RISKNs) is 1, was estimated as a ratio of the O/E
among subjects with atrophic mucosa to the O/E among the
subjects with non-atrophic mucosa. The 95% confidence
intervals (C195) were estimated for the risk ratios as test-
based limits (Breslow & Day, 1980).
Results
The observed and expected GCA frequencies with regard to
age of the patients and type and location of the tumour are
presented in Tables II and III. Three basic observations were
made. First, there is a significantly higher than expected
frequency of males among the IGCA cases, whereas no such
overrepresentation of either of the sexes is found among the
DGCA cases. Second, in the IGCA group there is an
Table I Distribution of males and females by
age groups in Finland in 1980
Age group Males Females
20-29 years 51% 49%
30-39 years 51% 49%
40-49 years 50% 50%
50-59 years 47% 53%
60-69 years 41% 59%
70-79 years 36% 64%
80- years 28% 72%
overrepresentation of males in all age strata irrespective of
location of the tumour. Third, the overrepresentation of
males and underrepresentation of females did not show any
statistically significant heterogeneity or trend with age.
The expected and observed GCA frequencies with respect
to presence of non-atrophic or atrophic mucosa in the
tumour-bearing area of the stomach, in addition to
consideration of age of the patient and type and location of
the tumour, are presented in Table IV. Two main
observations were made. First, there is among subjects with
non-atrophic and atrophic mucosa an overrepresentation of
males in comparison to females in the IGCA but not in the
DGCA group. Second, the risk of IGCA (RISKA1 A3) in
atrophic gastritis is of roughly similar magnitude in both
sexes when these risks are estimated as a ratio of O/E in the
N-S to the O/E in the Al-A3 groups: the RISKA,1A3 of
IGCA (when the risk of IGCA in N-S group is 1) is in
males 2.7 (1.2-5.7) and in females 4.1 (1.9-8.7). The
corresponding risk of DGCA is 1.1 (0.4-2.6) 0.9 in males
and 0.9 (0.4-1.9) in females.
Discussion
The present data suggest that the sex-bound risk of GCA
probably is a specific and independent risk factor. It seems
to be independent at least of age, it operates only in the
pathogenesis of IGCA, and seems to be independent of site
of the tumour in the stomach, and of AG.
The main objective of the present study was to examine
whether the overrepresentation of males and the under-
representation of females in GCA could be related to the
presence of AG. The AG is in mean a progressive, age-
dependent, stochastic process in the population (see Siurala
et al., 1984), and it is significantly associated with an
increased risk of GCA, particularly of IGCA (Siurala et al.,
1981; Sipponen et al., 1985). According to present
calculations, the AG-related risk of IGCA was found in both
sexes, and this risk was of same magnitude both in males
and females, suggesting that the sex- and AG-bound risks
are indeed independent. Moreover, a significant over-
representation of males and an underrepresentation of
females were similarly seen both in subjects with or without
AG.
However, the AG-related risk of IGCA seemed to be
slightly although insignificantly emphasized in females in
comparison to the AG-related risk in males. The reasons for
this possible slight inverse interaction between sex and AG is
unknown and can be an erroneous observation due to a
relatively small number of patients. However, it could also
mean that women with normal mucosa are particularly
immune to IGCA. This implies that the females can have a
substantially lower risk of IGCA than males also among
people with atrophic gastritis but that this difference is even
greater among people with normal, non-atrophic gastric
mucosa.
The sex-bound differences in the tumour pathogenesis may
be due to differences in the environment or in the dietary
habits. They may also be linked to effects of sex hormones
or to metabolic differences between males and females.
Available epidemiological observations, particularly those
showing a remarkable similarity in the male-to-female ratio
of GCA incidences between populations with very different
cultural environments and between different time periods
(Day, 1982; Howson et al., 1986; Sipponen et al., 1987;
Sandler & Holland, 1987), may support the hypothesis that
the sex-bound differences in the incidences of IGCA are due
to endogenous dissimilarities, either hormonal or metabolic,
between the sexes. In fact, steroid hormones have been
shown to both promote and inhibit the growth of GCA and
other upper GI-tumours in animals (Komada & Komada,
1986; Kitaoka, 1983,1984; Furukawa et al., 1982; Kimura et334 P. SIPPONEN et al.
Table II Intestinal type of GCA (IGCA). Distribution of observed (OBS) and expected (EXP) cases
of IGCA in males and females in different age groups in relation to location of the tumour in the
stomach. Differences between the male and female risks are calculated by the chi-square (x2) test
Differ.
Males Females between
male/female
OBS EXP OIE OBS EXP OIE risks RiskMa (CJ95)
All tumours
20-59 yrs 26 15.2 1.7 5 15.8 0.3 P<0.001 5.4 (1.7-17.0)
60-69 yrs 52 35.7 1.5 35 51.3 0.7 P<0.001 2.1 (1.2-3.9)
70-79 yrs 67 42.1 1.6 50 74.9 0.7 P<0.001 2.4 (1.4-4.0)
80- yrs 17 10.6 1.6 21 27.4 0.8 P<0.05 2.1 (0.8-5.4)
Total 162 103.6 1.6 111 164.4 0.7 P<0.001 2.3 (1.6-3.3)
Distal tumours
20-59 yrs 11 6.4 1.7 2 6.6 0.3 P<0.05 5.7 (0.9-34.6)
60-69 yrs 26 18.5 1.4 19 26.6 0.7 P<0.05 2.0 (0.8-4.6)
70-79 yrs 36 22.0 1.6 25 39.0 0.6 P<0.001 2.6 (1.2-5.3)
80- yrs 12 5.9 2.0 9 15.1 0.6 P<0.01 3.4 (0.9-12.3)
Total 85 52.8 1.6 55 87.3 0.6 P<0.001 2.6 (1.6-4.1)
Proximal tumours
20-59 yrs 15 8.8 1.7 3 9.2 0.3 P<0.01 5.2 (1.2-23.6)
60-69 yrs 26 17.2 1.5 16 24.8 0.7 P<0.01 2.3 (1.0-5.6)
70- yrs 36 24.9 1.5 37 48.1 0.8 P<0.01 1.9 (1.0-3.7)
Total 77 50.9 1.5 56 82.1 0.7 P<0.001 2.2 (1.4-3.6)
aRatio of male O/E to female O/E.
Table III Diffuse type of GCA (DGCA). Distribution of observed (OBS) and expected (EXP)
frequencies of DGCA in males and females in different age groups in relation to location of the
tumour in the stomach. Differences between the male and female risks are calculated by the chi-square
(x2) test
Differ.
Males Females between
male/female
OBS EXP OIE OBS EXP O/E risks RiskM2 (C195)
All tumours
20-39 yrs 13 14.3 0.9 15 13.7 1.1 NS 0.8 (0.3-2.4)
40-49 yrs 16 20.5 0.8 25 20.5 1.2 NS 0.6 (0.3-1.5)
50-59 yrs 31 29.1 1.0 31 32.9 0.9 NS 1.1 (0.6-2.3)
60-69 yrs 36 30.3 1.2 38 43.7 0.9 NS 1.4 (0.7-2.6)
70- yrs 24 17.8 1.4 30 36.2 0.8 NS 1.6 (0.7-3.6)
Total 120 112 1.1 139 147 0.9 NS 1.1 (0.7-3.6)
Distal tumours
20-49yrs 8 12.1 0.7 16 11.9 1.4 NS 0.5 (0.2-1.6)
50-59 yrs 11 8.9 1.2 8 10.1 0.8 NS 1.6 (0.4-5.7)
60-69 yrs 13 7.8 1.7 6 11.2 0.5 P<0.05 3.1 (0.8-11.8)
70- yrs 11 7.5 1.5 11 14.5 0.8 NS 1.9 (0.6-6.6)
Total 43 36.3 1.2 41 47.7 0.9 NS 1.4 (0.7-2.5)
Proximal tumours
20-49 yrs 21 22.7 0.9 24 22.3 1.1 NS 0.9 (0.4-2.0)
50-59 yrs 20 20.2 1.0 23 22.8 1.0 NS 1.0 (0.4-2.3)
60-69 yrs 23 22.6 1.0 32 32.5 1.0 NS 1.0 (0.5-2.2)
70- yrs 13 10.9 1.2 19 21.1 0.9 NS 1.3 (0.5-3.7)
Total 77 76.4 1.0 98 98.7 1.0 NS 1.0 (0.7-1.5)
aRatio of male O/E to female O/E.
al., 1980; Kobayashi, 1985). In addition, receptors for steroid
hormones have been found in human GI-cancers, also
including the GCA (Tokunaga et al., 1986), even though
conflicting reports have also been presented (Macbeth et al.,
1979). A therapeutic response to steroid sex hormones is
particularly demonstrated in GCAs of diffuse type (Kitaoka,
1983) in which, however, the sex-related differences in GCA
frequency, according to our present observations, seem to be
small or absent.
An additional explanation for the sex-related differences in
GCA frequencies could be that differences occur between the
sexes in the metabolisms of exogenous carcinogens (Goodall
& Lijinsky, 1984; Pfeiffer, 1979). It is known that GCA is
less easily induced by carcinogens in female than in male
animals (Goodall & Lijinsky, 1984; Morino et al., 1982).
Environmental carcinogens are also considered to be the
most probable cause of GCA, particularly of IGCA, also in
man (Pfeiffer, 1979; Mirvish, 1983; Cuello et al., 1976;
Haenszel et al., 1976). Thus, differences in the metabolism of
carcinogens between males and females may operate in this
context also in human beings, and they may modify the
development of GCA between the sexes. The present
observations appear to be in line with these animal models:
females with normal gastric mucosa tend to be, in
comparison to males, particularly resistant to IGCA.
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Table IV Observed (OBS) and expected (EXP) frequencies of GCA cases in males and females in
IGCA and DGCA groups in relation to the presence of non-atrophic (N-S) and atrophic (Al-A3)
mucosa in the tumour-bearing area of the stomach. Differences between the male and female risks are
calculated by the likelihood ratio G-test
Differ.
Males Females between
male/female
OBS EXP OIE OBS EXP O/E risks RiskMa (C195)
IGCA
non-atrophic 24 27.9 0.9 13 43.1 0.3 P<0.001 2.9 (1.3-6.5)
atrophic 46 20.0 2.3 42 34.0 1.2 P<0.001 1.9 (0.9-3.7)
DGCA
non-atrophic 34 35.9 0.9 47 44.4 1.1 NS 0.9 (0.5-1.7)
atrophic 14 13.6 1.0 17 18.1 0.9 NS 1.1 (0.4-3.0)
aRatio of male O/E to female O/E.
absent. In fact, DGCA has been shown to differ from IGCA
in many biological and epidemiological respects (see Meister
et al., 1979; Siurala et al., 1981; Lauren, 1965; Johansen,
1981). The DGCA is the prevailing cancer type in young age
groups, affects commonly the gastric body mucosa, is
probably more closely linked to genetic factors than IGCA,
and may have a poorer prognosis (see Siurala et al., 1981).
In addition, it is considered that DGCA is not clearly
pathogenetically related to AG (Johansen, 1981; Sipponen et
al., 1983,1984; Jarvi & Lauren, 1951; Lauren, 1965). The
present calculations also suggest that AG is not a risk
condition of DGCA: the relative risk of DGCA in atrophic
gastritis varied around unity in both sexes. On the other
hand, the relative risk of IGCA in atrophic gastritis was 2.7
(1.2-5.7) and 4.1 (1.2-8.7) in males and females, respectively,
the figures which correspond the magnitude of relative risks
obtained also in other studies (see Sipponen et al., 1984).
We conclude that some sex-bound factors, which possibly
are hormonal or metabolic in nature, play a role in the
genesis at least in a proportion of gastric carcinomas of the
intestinal type (IGCA). We consider that these sex-bound
factors, which lead to an overrepresentation of IGCA (and
of GCA in general) among males and to an under-
representation of IGCA among females, are not related to
age and location of the tumour in the stomach, and are not
consequences of the risk that is mediated by AG.
The study was supported by grants from the Yrjo Jahnsson
Foundation and from the Paulo Foundation, Helsinki, Finland.
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